<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04018586</url>
  </required_header>
  <id_info>
    <org_study_id>AVACENFBG</org_study_id>
    <nct_id>NCT04018586</nct_id>
  </id_info>
  <brief_title>AVACEN Hand Heating on Fasting Blood Glucose</brief_title>
  <official_title>AVACEN Treatment Method on Fasting and Postprandial Blood Glucose</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Jeff Moore</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>San Diego State University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      A double-blind crossover randomized controlled trial to investigate the effects of the AVACEN
      device on fasting blood glucose. The AVACEN device creates negative pressure around the hand
      while heating the palm. Two sham devices, one providing heat but no vacuum and one providing
      neither heat nor vacuum were also used. Each subject was tested while using each of these
      three devices on separate visits. Subjects arrived in the morning following an overnight
      fast. Fasting blood glucose, blood pressure, tympanic temperature, and subjective thermal
      ratings were measured before and throughout the 30 minutes that the device was used.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 28, 2019</start_date>
  <completion_date type="Actual">September 15, 2019</completion_date>
  <primary_completion_date type="Actual">September 15, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Fasting Blood Glucose</measure>
    <time_frame>30 minutes</time_frame>
    <description>Change in fasting blood glucose after 30 minutes of use of AVACEN device</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Blood Pressure</measure>
    <time_frame>30 minutes</time_frame>
    <description>Change in blood pressure after 30 minutes of use of AVACEN device</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tympanic Temperature</measure>
    <time_frame>30 minutes</time_frame>
    <description>Change in tympanic temperature after 30 minutes of use of AVACEN device</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ASHRAE 7 point thermal sensation scale</measure>
    <time_frame>30 minutes</time_frame>
    <description>Change in subjective temperature after 30 minutes of use of AVACEN device</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">17</enrollment>
  <condition>Hyperglycemia</condition>
  <condition>Hypertension</condition>
  <arm_group>
    <arm_group_label>Heat and Vacuum</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>AVACEN 100 device applies heat and vacuum to hand</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Heat Only</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>AVACEN 100 device with heat only</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>AVACEN 100 device with neither heat nor vacuum</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>AVACEN 100</intervention_name>
    <description>AVACEN 100 pulls a -30mmHg vacuum around hand from wrist down and applies heat (108 farenheit) to the palm and will be applied for 30 minutes</description>
    <arm_group_label>Heat and Vacuum</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>AVACEN 100 Heat Only</intervention_name>
    <description>AVACEN 100 applies heat (108 Fahrenheit) to the palm and will be applied for 30 minutes</description>
    <arm_group_label>Heat Only</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>AVACEN Sham</intervention_name>
    <description>AVACEN 100 neither heats nor pulls a vacuum to hand</description>
    <arm_group_label>Sham</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy subjects

        Exclusion Criteria:

          -  Diabetes diagnosis, diabetes medication, blood pressure medication
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jeff M Moore, B.S./B.S.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Graduate Student</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>San Diego State University</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92182</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2019</verification_date>
  <study_first_submitted>July 6, 2019</study_first_submitted>
  <study_first_submitted_qc>July 11, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">July 12, 2019</study_first_posted>
  <last_update_submitted>October 26, 2019</last_update_submitted>
  <last_update_submitted_qc>October 26, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">October 29, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>San Diego State University</investigator_affiliation>
    <investigator_full_name>Jeff Moore</investigator_full_name>
    <investigator_title>Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyperglycemia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

